Met Life Investment Management, LLC Cardiovascular Systems Inc Transaction History

Met Life Investment Management, LLC

$17.1 Billion
Q3 2024

36 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2024	BUY	$13.31 - $19.86 $286,697 - $427,784	21,540 New	21,540 $428 Million
Q1 2023 May 15, 2023	SELL	$13.31 - $19.86 $17,090 - $25,500	-1,284 Reduced 5.63%	21,540 $427,000
Q4 2022 Jun 14, 2023	BUY	$12.74 - $15.12 $16,358 - $19,414	1,284 Added 5.96%	22,824 $310,000
Q3 2022 Jun 14, 2023	BUY	$12.93 - $17.17 $16,602 - $22,046	1,284 Added 5.96%	22,824 $316,000
Q2 2022 Jun 20, 2023	BUY	$13.53 - $23.34 $17,372 - $29,968	1,284 Added 5.96%	22,824 $327,000
Q1 2022 May 10, 2024	BUY	$16.14 - $22.6 $368,379 - $515,822	22,824 New	22,824 $515,000
Q1 2022 Jun 20, 2023	BUY	$16.14 - $22.6 $20,723 - $29,018	1,284 Added 5.96%	22,824 $515,000
Q1 2022 Mar 22, 2023	BUY	$16.14 - $22.6 $145,050 - $203,106	8,987 Added 64.95%	22,824 $515,000
Q1 2022 May 12, 2022	BUY	$16.14 - $22.6 $145,050 - $203,106	8,987 Added 64.95%	22,824 $516,000
Q4 2021 Jun 21, 2023	SELL	$18.64 - $36.77 $143,583 - $283,239	-7,703 Reduced 35.76%	13,837 $259,000
Q3 2021 May 17, 2024	SELL	$32.83 - $43.0 $91,267 - $119,540	-2,780 Reduced 16.73%	13,837 $454,000
Q3 2021 Jun 21, 2023	SELL	$32.83 - $43.0 $252,889 - $331,229	-7,703 Reduced 35.76%	13,837 $454,000
Q3 2021 Mar 22, 2023	SELL	$32.83 - $43.0 $91,267 - $119,540	-2,780 Reduced 16.73%	13,837 $454,000
Q3 2021 Nov 15, 2021	SELL	$32.83 - $43.0 $91,267 - $119,540	-2,780 Reduced 16.73%	13,837 $454,000
Q2 2021 Jun 21, 2023	SELL	$34.41 - $44.03 $169,400 - $216,759	-4,923 Reduced 22.86%	16,617 $708,000
Q1 2021 May 17, 2024	BUY	$37.29 - $47.19 $619,647 - $784,156	16,617 New	16,617 $637,000
Q1 2021 Jun 26, 2023	SELL	$37.29 - $47.19 $183,578 - $232,316	-4,923 Reduced 22.86%	16,617 $637 Million
Q4 2020 Jun 22, 2023	SELL	$34.3 - $44.09 $168,858 - $217,055	-4,923 Reduced 22.86%	16,617 $727,000
Q3 2020 May 24, 2024	BUY	$27.86 - $39.35 $46,414 - $65,557	1,666 Added 11.14%	16,617 $654 Million
Q3 2020 Jun 26, 2023	SELL	$27.86 - $39.35 $137,154 - $193,720	-4,923 Reduced 22.86%	16,617 $653,000
Q3 2020 Mar 22, 2023	BUY	$27.86 - $39.35 $46,414 - $65,557	1,666 Added 11.14%	16,617 $653,000
Q3 2020 Nov 13, 2020	BUY	$27.86 - $39.35 $46,414 - $65,557	1,666 Added 11.14%	16,617 $654,000
Q2 2020 May 24, 2024	BUY	$30.3 - $42.55 $453,015 - $636,165	14,951 New	14,951 $472 Million
Q2 2020 Jun 26, 2023	SELL	$30.3 - $42.55 $199,646 - $280,361	-6,589 Reduced 30.59%	14,951 $471,000
Q1 2020 Jul 12, 2023	SELL	$30.0 - $54.18 $197,670 - $356,992	-6,589 Reduced 30.59%	14,951 $526,000
Q4 2019 Jul 12, 2023	SELL	$42.29 - $52.2 $278,648 - $343,945	-6,589 Reduced 30.59%	14,951 $726,000
Q3 2019 Jul 12, 2023	SELL	$42.06 - $51.64 $277,133 - $340,255	-6,589 Reduced 30.59%	14,951 $710,000
Q2 2019 Jul 12, 2023	SELL	$33.93 - $43.66 $223,564 - $287,675	-6,589 Reduced 30.59%	14,951 $641,000
Q1 2019 Jul 13, 2023	SELL	$26.74 - $41.32 $176,189 - $272,257	-6,589 Reduced 30.59%	14,951 $578,000
Q4 2018 Jul 13, 2023	SELL	$25.26 - $38.43 $166,438 - $253,215	-6,589 Reduced 30.59%	14,951 $425,000
Q4 2018 Mar 22, 2023	SELL	$25.26 - $38.43 $227,036 - $345,408	-8,988 Reduced 37.55%	14,951 $425,000
Q4 2018 Feb 14, 2019	SELL	$25.26 - $38.43 $227,036 - $345,408	-8,988 Reduced 37.55%	14,951 $426,000
Q3 2018 Jul 13, 2023	SELL	$33.27 - $39.25 $219,216 - $258,618	-6,589 Reduced 30.59%	14,951 $585,000
Q3 2018 Mar 22, 2023	BUY	$33.27 - $39.25 $37,096 - $43,763	1,115 Added 4.89%	23,939 $936,000
Q3 2018 Nov 14, 2018	BUY	$33.27 - $39.25 $299,030 - $352,779	8,988 Added 60.12%	23,939 $937,000
Q4 2017 Feb 15, 2018	BUY	$23.37 - $29.26 $349,404 - $437,466	14,951	14,951 $354,000

Others Institutions Holding CSII

# of Institutions

Shares Held

35.5K

Call Options Held

Put Options Held

View Full List

About Cardiovascular Systems Inc

Ticker CSII
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 41,905,900
Description
Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including...

More about CSII

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account